• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射免疫球蛋白替代疗法对慢性鼻窦肺部疾病低丙种球蛋白血症患者的益处。

Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease.

作者信息

Roifman C M, Lederman H M, Lavi S, Stein L D, Levison H, Gelfand E W

出版信息

Am J Med. 1985 Aug;79(2):171-4. doi: 10.1016/0002-9343(85)90006-3.

DOI:10.1016/0002-9343(85)90006-3
PMID:4025374
Abstract

Seven patients with hypogammaglobulinemia and chronic sinopulmonary infections were treated with a preparation of intravenous gammaglobulin. In order to maintain levels of serum IgG at greater than 500 to 750 mg/dl four weeks after infusion, 0.6 g/kg was administered every month. Stable serum levels were achieved after three to eight months. After six to 12 months of this regimen, there was significant reduction in acute infections requiring hospitalization, amelioration of clinical and radiographic evidence of chronic maxillary sinusitis, and improvement in pulmonary symptoms and pulmonary function test results. The administration of increased amounts of IgG intravenously is of benefit in patients with chronic sinopulmonary infections.

摘要

7例低丙种球蛋白血症合并慢性鼻窦肺部感染患者接受了静脉注射丙种球蛋白制剂治疗。为使输注后4周血清IgG水平维持在大于500至750mg/dl,每月给予0.6g/kg。3至8个月后达到稳定的血清水平。该治疗方案实施6至12个月后,需要住院治疗的急性感染显著减少,慢性上颌窦炎的临床和影像学证据得到改善,肺部症状及肺功能测试结果也有所改善。静脉注射增加剂量的IgG对慢性鼻窦肺部感染患者有益。

相似文献

1
Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease.静脉注射免疫球蛋白替代疗法对慢性鼻窦肺部疾病低丙种球蛋白血症患者的益处。
Am J Med. 1985 Aug;79(2):171-4. doi: 10.1016/0002-9343(85)90006-3.
2
Replacement therapy with high dose intravenous gamma-globulin improves chronic sinopulmonary disease in patients with hypogammaglobulinemia.大剂量静脉注射γ-球蛋白替代疗法可改善低丙种球蛋白血症患者的慢性鼻窦肺部疾病。
Pediatr Infect Dis J. 1988 May;7(5 Suppl):S92-6.
3
Penetration of administered IgG into the maxillary sinus and long-term clinical effects of intravenous immunoglobulin replacement therapy on sinusitis in primary hypogammaglobulinaemia.静脉注射免疫球蛋白替代疗法中给予的免疫球蛋白在上颌窦的渗透情况及其对原发性低丙种球蛋白血症患者鼻窦炎的长期临床疗效。
Acta Otolaryngol. 1991;111(3):550-5. doi: 10.3109/00016489109138382.
4
Respiratory Health and Related Quality of Life in Patients with Congenital Agammaglobulinemia in the Northern Region of the UK.英国北部先天性无丙种球蛋白血症患者的呼吸健康及相关生活质量
J Clin Immunol. 2016 Jul;36(5):472-9. doi: 10.1007/s10875-016-0284-3. Epub 2016 Apr 18.
5
An evaluation of the safety of three intravenous immunoglobulin preparations in patients with primary hypogammaglobulinaemia.三种静脉注射免疫球蛋白制剂用于原发性低丙种球蛋白血症患者的安全性评估。
J Infect. 1986 Jan;12(1):5-10. doi: 10.1016/s0163-4453(86)94717-1.
6
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease.高剂量与低剂量静脉注射免疫球蛋白治疗低丙种球蛋白血症和慢性肺病的疗效比较
Lancet. 1987 May 9;1(8541):1075-7. doi: 10.1016/s0140-6736(87)90494-6.
7
Effectiveness of treatment of children with hypogammaglobulinemia: comparison of fresh plasma and intravenous immunoglobulin preparation.低丙种球蛋白血症患儿的治疗效果:新鲜血浆与静脉注射免疫球蛋白制剂的比较
Arch Immunol Ther Exp (Warsz). 1986;34(4):377-84.
8
Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.儿童无丙种球蛋白血症的早期及长期静脉注射免疫球蛋白替代疗法:31例患者的回顾性调查
J Pediatr. 1999 May;134(5):589-96. doi: 10.1016/s0022-3476(99)70246-5.
9
Increase of serum immunoglobulin level into the normal range in primary hypogammaglobulinaemia by dosage individualization of intravenous immunoglobulin.通过静脉注射免疫球蛋白剂量个体化使原发性低丙种球蛋白血症患者血清免疫球蛋白水平升至正常范围
Vox Sang. 1986;51(4):278-86. doi: 10.1111/j.1423-0410.1986.tb01969.x.
10
Intravenous gammaglobulin treatment in patients with hypogammaglobulinaemia.低丙种球蛋白血症患者的静脉注射丙种球蛋白治疗
Br Med J (Clin Res Ed). 1984 Nov 3;289(6453):1177-8. doi: 10.1136/bmj.289.6453.1177.

引用本文的文献

1
Fecal Immunoglobulin Levels as a Modifier of the Gut Microbiome in Patients with Common Variable Immunodeficiency.粪便免疫球蛋白水平作为常见可变免疫缺陷患者肠道微生物组的调节剂。
J Clin Immunol. 2023 Aug;43(6):1208-1220. doi: 10.1007/s10875-023-01469-9. Epub 2023 Mar 24.
2
Immune globulin therapy and kidney disease: Overview and screening, monitoring, and management recommendations.免疫球蛋白治疗与肾脏疾病:概述及筛查、监测和管理建议。
Am J Health Syst Pharm. 2022 Aug 19;79(17):1415-1423. doi: 10.1093/ajhp/zxac139.
3
Comprehensive phenotyping of human peripheral blood B lymphocytes in pathological conditions.
在病理条件下对人外周血 B 淋巴细胞进行全面表型分析。
Cytometry A. 2022 Feb;101(2):140-149. doi: 10.1002/cyto.a.24518. Epub 2021 Dec 1.
4
II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.二、巴西关于原发性免疫缺陷患者使用人免疫球蛋白的共识
Einstein (Sao Paulo). 2017;15(1):1-16. doi: 10.1590/S1679-45082017AE3844.
5
Long-term Clinical Outcome of Antibody Replacement Therapy in Humoral Immunodeficient Adults With Respiratory Tract Infections.呼吸道感染的体液免疫缺陷成人的抗体替代疗法的长期临床结果。
EBioMedicine. 2017 Apr;18:254-260. doi: 10.1016/j.ebiom.2017.03.025. Epub 2017 Mar 21.
6
Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex 10% Versus Gammaplex 5% in Subjects with Primary Immunodeficiency.原发性免疫缺陷受试者中10% 伽马复宁与5% 伽马复宁的安全性、耐受性及药代动力学评估。
J Clin Immunol. 2017 Apr;37(3):301-310. doi: 10.1007/s10875-017-0383-9. Epub 2017 Mar 18.
7
Increased Incidence of Fatigue in Patients with Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry.原发性免疫缺陷病患者疲劳发生率增加:美国免疫缺陷网络登记处的患病率及相关性
J Clin Immunol. 2017 Feb;37(2):153-165. doi: 10.1007/s10875-016-0367-1. Epub 2017 Jan 26.
8
Clinical Experience with Octagam® 10 %, a solvent detergent virus inactivated intravenous immunoglobulin: a Canadian retrospective review of utilization.Octagam® 10%(一种经溶剂去污剂灭活病毒的静脉注射免疫球蛋白)的临床经验:加拿大使用情况的回顾性研究
Allergy Asthma Clin Immunol. 2016 Jul 27;12:32. doi: 10.1186/s13223-016-0138-9. eCollection 2016.
9
Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases.皮下免疫球蛋白疗法:原发性免疫缺陷病患者的一种新选择。
Biologics. 2012;6:277-87. doi: 10.2147/BTT.S25188. Epub 2012 Aug 24.
10
Carbamazepine-induced agammagloblinaemia clinically mimicking diffuse panbronchiolitis.卡马西平诱发的无丙种球蛋白血症,临床表现酷似弥漫性泛细支气管炎。
BMJ Case Rep. 2011 Feb 16;2011:bcr1120103535. doi: 10.1136/bcr.11.2010.3535.